Dyne Therapeutics, Inc. (DYN)

17.92 +1.11 (+6.60%) USD  |  NASDAQ  |  Jun 09, 16:00
17.50 -0.42 (-2.34%) Pre-Market: 08:10
More

Dyne Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for DYN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Vor Biopharma, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
Imunon, Inc. Upgrade